PubRank

Carlo Salvarani

Author PubWeight™ 111.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Retroperitoneal fibrosis. Lancet 2006 4.57
2 Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 2007 3.81
3 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2012 3.47
4 Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 2011 3.19
5 Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2004 2.43
6 Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol 2007 2.33
7 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum 2012 2.25
8 Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol 2012 2.18
9 Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol 2011 1.52
10 Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica. Rheumatology (Oxford) 2009 1.49
11 Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? Arthritis Care Res (Hoboken) 2012 1.46
12 Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin? Clin Exp Rheumatol 2014 1.43
13 EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010 1.38
14 Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet 2013 1.34
15 Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum 2008 1.30
16 Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken) 2013 1.29
17 Patient-reported outcomes in polymyalgia rheumatica. J Rheumatol 2012 1.20
18 Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol 2009 1.17
19 The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2011 1.12
20 Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol 2007 1.09
21 (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis. Arthritis Rheum 2005 1.05
22 Is (18)F fluorodeoxyglucose positron emission tomography useful to assess activity of myositis? J Rheumatol 2013 1.05
23 Diagnosis and treatment of giant cell arteritis. Drugs Aging 2008 1.03
24 International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum 2009 1.02
25 Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol 2002 1.02
26 Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis 2010 1.01
27 New approaches in the treatment of Adamantiades-Behçet's disease. Curr Opin Rheumatol 2006 1.01
28 Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases. Rheumatol Int 2007 1.01
29 Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol 2012 1.00
30 Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol 2014 1.00
31 Etanercept in the longterm treatment of patients with ankylosing spondylitis. J Rheumatol 2009 1.00
32 Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy. Clin Exp Rheumatol 2011 0.99
33 Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum 2004 0.98
34 Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 2006 0.97
35 The role of infectious agents in the pathogenesis of vasculitis. Best Pract Res Clin Rheumatol 2008 0.97
36 Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study. Arthritis Rheum 2006 0.95
37 Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol 2006 0.94
38 Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. Rheumatology (Oxford) 2013 0.94
39 Seronegative spondyloarthritides. Best Pract Res Clin Rheumatol 2002 0.94
40 Tumor necrosis factor-alpha protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction. J Rheumatol 2006 0.93
41 Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum 2002 0.93
42 IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. Ann Rheum Dis 2012 0.93
43 Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol 2003 0.92
44 Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine 2010 0.92
45 Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature. Semin Arthritis Rheum 2013 0.92
46 Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor alpha therapy: is there a need for more comprehensive screening procedures? Arthritis Rheum 2009 0.92
47 Idiopathic aortitis: an underrecognized vasculitis. Arthritis Res Ther 2011 0.91
48 Workshop report: clinical diagnosis and imaging of sacroiliitis, Innsbruck, Austria, October 9, 2003. J Rheumatol 2004 0.91
49 Update on polymyalgia rheumatica. Eur J Intern Med 2013 0.90
50 Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis 2013 0.90
51 Chronic periaortitis: a large-vessel vasculitis? Curr Opin Rheumatol 2011 0.90
52 Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum 2004 0.89
53 Role of imaging in the diagnosis of large and medium-sized vessel vasculitis. Rheum Dis Clin North Am 2013 0.89
54 Isolated knee monoarthritis heralding resectable non-small-cell lung cancer. A paraneoplastic syndrome not previously described. Ann Rheum Dis 2007 0.89
55 Retroperitoneal fibrosis: evolving concepts. Rheum Dis Clin North Am 2007 0.88
56 Are steroids alone sufficient for the treatment of giant cell arteritis? Best Pract Res Clin Rheumatol 2005 0.87
57 Imaging findings in primary central nervous system vasculitis. Clin Exp Rheumatol 2011 0.87
58 18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series. Clin Exp Rheumatol 2012 0.86
59 Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis. J Rheumatol 2009 0.86
60 Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study. Rheumatology (Oxford) 2010 0.85
61 Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis. Clin Exp Rheumatol 2011 0.85
62 Primary central nervous system vasculitis: pathology and mechanisms. Acta Neuropathol 2012 0.85
63 Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. Rheumatology (Oxford) 2011 0.85
64 Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria. Clin Exp Rheumatol 2013 0.84
65 Efficacy and safety of tocilizumab in refractory rheumatoid arthritis: a real life cohort from a single centre. Clin Exp Rheumatol 2014 0.84
66 G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis. Invest Ophthalmol Vis Sci 2010 0.83
67 Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study. Arthritis Rheum 2007 0.83
68 Wegener granulomatosis with spleen infarction: case report and review of the literature. Semin Arthritis Rheum 2007 0.83
69 A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet's disease. Arthritis Rheum 2011 0.82
70 Interleukin-10 promoter polymorphisms in giant cell arteritis. Arthritis Rheum 2006 0.82
71 Role of imaging in vasculitis and connective tissue diseases. Best Pract Res Clin Rheumatol 2008 0.82
72 The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept. Clin Exp Rheumatol 2011 0.81
73 Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica. Clin Exp Rheumatol 2014 0.81
74 Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis. Arthritis Rheum 2012 0.81
75 Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis. Arthritis Rheum 2011 0.81
76 Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis. Clin Exp Rheumatol 2013 0.81
77 Do we need treatment with tumour necrosis factor blockers for giant cell arteritis? Ann Rheum Dis 2008 0.81
78 Differential effects of anti-TNF-alpha drugs on fibroblast-like synoviocyte apoptosis. Rheumatology (Oxford) 2009 0.80
79 Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab. Clin Exp Rheumatol 2013 0.80
80 Etanercept in spondyloarthopathies. Part II: safety and pharmacoeconomic issues. Clin Exp Rheumatol 2011 0.80
81 [18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis. Rheumatology (Oxford) 2012 0.80
82 NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica. Ann Rheum Dis 2013 0.80
83 Renal cell carcinoma mimicking polymyalgia rheumatica. Clues for a correct diagnosis. Scand J Rheumatol 2002 0.79
84 Etanercept in spondyloarthropathies. Part I: current evidence of efficacy. Clin Exp Rheumatol 2011 0.79
85 Pericarditis heralding Erdheim-Chester disease. Circulation 2008 0.79
86 Soluble receptor activator of nuclear factor- kappaB Ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases. Biogerontology 2004 0.79
87 Fast spin echo-T2-weighted sequences with fat saturation in toe dactylitis of spondyloarthritis. Clin Rheumatol 2008 0.79
88 Fat suppression magnetic resonance imaging in shoulders of patients with polymyalgia rheumatica. J Rheumatol 2004 0.79
89 CC chemokine receptor 5 polymorphism in chronic periaortitis. Rheumatology (Oxford) 2011 0.79
90 Comparison between colour duplex sonography findings and different histological patterns of temporal artery. Rheumatology (Oxford) 2013 0.78
91 Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum 2013 0.78
92 Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk. Arthritis Rheum 2008 0.78
93 CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease. Rheumatology (Oxford) 2012 0.78
94 Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in southern europe. J Rheumatol 2004 0.78
95 Primary central nervous system vasculitis: Is it a single disease? Ann Neurol 2010 0.78
96 TLR-4 and VEGF polymorphisms in chronic periaortitis. PLoS One 2013 0.78
97 Images in cardiovascular medicine. Chronic periaortitis. Circulation 2008 0.78
98 Anterior ischaemic optic neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature. Clin Exp Rheumatol 2013 0.78
99 Ultrasonographic predictors for the development of joint damage in rheumatoid arthritis patients: a single joint prospective study. Clin Exp Rheumatol 2013 0.77
100 Rheumatic manifestations of scurvy. Curr Rheumatol Rep 2015 0.77
101 Systemic lupus erythematosus (SLE) in Italy: an Italian prevalence study based on a two-step strategy in an area of Florence (Scandicci-Le Signe). Med Sci Monit 2005 0.77
102 Evidence of association of the NLRP1 gene with giant cell arteritis. Ann Rheum Dis 2012 0.77
103 IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population. Rheumatol Int 2012 0.77
104 Recommendations of the Italian Society of Rheumatology for the treatment of the primary large-vessel vasculitis with biological agents. Clin Exp Rheumatol 2012 0.77
105 New indications for biological therapies. Intern Emerg Med 2011 0.76
106 Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis. Clin Exp Rheumatol 2012 0.76
107 CC chemokine receptor 5 polymorphism in Italian patients with giant cell arteritis. Mod Rheumatol 2012 0.76
108 Improving therapeutic options for patients with giant cell arteritis. Curr Opin Rheumatol 2008 0.76
109 Persistent efficacy of tumor necrosis factor alpha blockage therapy in SAPHO syndrome: comment on the article by Wagner et al. Arthritis Rheum 2003 0.76
110 Searching for viral antibodies and genome in intraocular fluids of patients with Fuchs uveitis and non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol 2013 0.76
111 Occasional detection of thymic epithelial tumor 4 years after diagnosis of adult onset Still disease: A challenging case report and immuno-oncological considerations coming from pertinent literature review. Medicine (Baltimore) 2016 0.75
112 Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study. Medicine (Baltimore) 2016 0.75
113 Tumor necrosis factor blocking agents in polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 2008 0.75
114 Clinical images: PET-CT and contrast-enhanced ultrasound in Takayasu's arteritis. Rheumatology (Oxford) 2013 0.75
115 Treatment of large-vessel vasculitis: where do we stand? Clin Exp Rheumatol 2011 0.75
116 CD25 blockade for refractory polymyositis. Clin Exp Rheumatol 2013 0.75
117 Scurvy mimicking spondyloarthritis in a young man. Clin Exp Rheumatol 2013 0.75
118 TIR-domain-containing adaptor protein gene TIRAP S180L polymorphism is not increased in Behçet's disease patients in two ethnic cohorts. Clin Exp Rheumatol 2013 0.75
119 Myocardial positron emission tomography/computed tomography scan revealing right coronary artery involvement in large vessel vasculitis. J Rheumatol 2012 0.75
120 L30. Assessment of vasculitis extent and severity. Presse Med 2013 0.75
121 Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy. Sci Rep 2017 0.75
122 Isolated vasculitis of the lower extremities in a patient with polymyalgia rheumatica and giant cell arteritis. Clin Exp Rheumatol 2011 0.75
123 PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease. Clin Exp Rheumatol 2011 0.75
124 Extra-articular rheumatoid arthritis imaged by [18F]FDG-PET/CT. Acta Reumatol Port 2016 0.75
125 Systemic vasculitis: state of the art and emerging concepts. Curr Opin Rheumatol 2006 0.75
126 Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with peripheral involvement requiring second-line drugs. J Rheumatol Suppl 2009 0.75
127 The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis. Clin Exp Rheumatol 2014 0.75
128 Ankylosing spondylitis: a difficult diagnosis in patients on long-term renal replacement therapy. J Nephrol 2002 0.75
129 Initiative for quality in psoriasis and psoriatic arthritis. J Rheumatol 2008 0.75
130 Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. Adv Ther 2014 0.75
131 The INTERnational Study on Primary Angiitis of the CEntral nervous system--a call to the world. Int J Stroke 2014 0.75